Selected article for: "antibody affinity and different affinity"
Author: Bayarri-Olmos, Rafael; Jarlhelt, Ida; Johnsen, Laust Bruun; Hansen, Cecilie Bo; Helgstrand, Charlotte; Rose Bjelke, Jais; Matthiesen, Finn; Nielsen, Susanne Dam; Iversen, Kasper Karmark; Ostrowski, Sisse Rye; Bundgaard, Henning; Frikke-Schmidt, Ruth; Garred, Peter; Skjoedt, Mikkel-Ole
Title: Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
  • Cord-id: egqbnybo
  • Document date: 2021_10_7
    • ID: egqbnybo
    Snippet: The recent identification and rise to dominance of the P.1 and B.1.351 SARS-CoV-2 variants have brought international concern because they may confer fitness advantages. The same three positions in the receptor-binding domain (RBD) are affected in both variants, but where the 417 substitution differs, the E484K/N501Y have co-evolved by convergent evolution. Here we characterize the functional and immune evasive consequences of the P.1 and B.1.351 RBD mutations. E484K and N501Y result in gain-of-
    Document: The recent identification and rise to dominance of the P.1 and B.1.351 SARS-CoV-2 variants have brought international concern because they may confer fitness advantages. The same three positions in the receptor-binding domain (RBD) are affected in both variants, but where the 417 substitution differs, the E484K/N501Y have co-evolved by convergent evolution. Here we characterize the functional and immune evasive consequences of the P.1 and B.1.351 RBD mutations. E484K and N501Y result in gain-of-function with two different outcomes: The N501Y confers a ten-fold affinity increase towards ACE-2, but a modest antibody evasion potential of plasma from convalescent or vaccinated individuals, whereas the E484K displays a significant antibody evasion capacity without a major impact on affinity. On the other hand, the two different 417 substitutions severely impair the RBD/ACE-2 affinity, but in the combined P.1 and B.1.351 RBD variants, this effect is partly counterbalanced by the effect of the E484K and N501Y. Our results suggest that the combination of these three mutations is a two-step forward and one step back in terms of viral fitness.

    Search related documents:
    Co phrase search for related documents
    • ace affinity and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • ace affinity and low affinity: 1
    • acute respiratory syndrome and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory syndrome and lung cell receptor: 1, 2, 3
    • acute respiratory syndrome and lysine substitution: 1
    • acute respiratory syndrome and mabs convalescent sera: 1, 2, 3
    • acute respiratory syndrome and mabs panel: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and mabs recognition: 1
    • acute respiratory syndrome coronavirus and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome coronavirus and lung cell receptor: 1, 2, 3
    • acute respiratory syndrome coronavirus and lysine substitution: 1
    • acute respiratory syndrome coronavirus and mabs convalescent sera: 1, 2, 3
    • acute respiratory syndrome coronavirus and mabs panel: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome coronavirus and mabs recognition: 1